- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Bisoprolol Fumarate.
Displaying page 1 of 1.
EudraCT Number: 2017-002443-15 | Sponsor Protocol Number: ICAF-BETA | Start Date*: 2017-09-20 | |||||||||||
Sponsor Name:York Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Improving cardiac function in high-risk surgical patients: exercise testing, biomarkers and beta-blockade | |||||||||||||
Medical condition: Impaired VE/CO2 on cardio pulmonary exercise testing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001683-37 | Sponsor Protocol Number: 2018012805 | Start Date*: 2018-07-03 |
Sponsor Name:Rigshospitalet | ||
Full Title: The RIME-IVF study Investigation of RIsk factors in out-of-hospital-cardiac-arrest patients, and MEdical treatment in Idiopathic Ventricular Fibrillation patients | ||
Medical condition: Unexplained cardiac arrest patients after thorough investigations (Idiopathic ventricular fibrillation, IVF) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002779-24 | Sponsor Protocol Number: 3.089.17 | Start Date*: 2018-06-12 | ||||||||||||||||
Sponsor Name:University of Aberdeen [...] | ||||||||||||||||||
Full Title: A randomised, double-blind placebo controlled trial of the effectiveness of the beta-blocker bisoprolol in preventing exacerbations of chronic obstructive pulmonary disease. | ||||||||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006008-11 | Sponsor Protocol Number: ANDA2 | Start Date*: 2012-08-22 | |||||||||||
Sponsor Name:Tayside Clinical Trials Unit, University of Dundee | |||||||||||||
Full Title: Evaluation of effects of chronic dose exposure to cardioselective and non-cardioselective beta blockers on measures of cardiopulmonary function in moderate to severe COPD. | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007149-30 | Sponsor Protocol Number: 4500 | Start Date*: 2009-01-14 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge [...] | |||||||||||||
Full Title: Optimal Treatment of Drug Resistant Hypertension | |||||||||||||
Medical condition: Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000207-13 | Sponsor Protocol Number: 2012RC22 | Start Date*: 2015-09-17 | |||||||||||
Sponsor Name:Tayside Clinical Trials Unit, University of Dundee | |||||||||||||
Full Title: Proof of concept study to assess the differential effects of chronic beta-blockade (celiprolol versus bisoprolol) on cardiopulmonary outcomes at rest and during exercise in chronic obstructive pulm... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003286-21 | Sponsor Protocol Number: SVUH-UCD-LEAD/CAR/01/2014 | Start Date*: 2015-08-17 | |||||||||||
Sponsor Name:University College Dublin | |||||||||||||
Full Title: A multicentre, interventional, parallel group, randomised, open-label, exploratory study to assess the earlier introduction of Ivabradine in the Management of Systolic Dysfunction Heart Failure. Th... | |||||||||||||
Medical condition: Heart Failure with reduced ejection fraction and borderline systolic blood pressure. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020357-14 | Sponsor Protocol Number: CCFM154/310 | Start Date*: 2011-05-16 |
Sponsor Name:FONDAZIONE MONZINO CENTRO CARDIOLOGICO | ||
Full Title: EFFECTS OF BETA 2 RECEPTOR BLOCKADE ON PULMONARY FUNCTION IN A HUMAN MODEL OF ACUTE HYDRIC OVERLOAD | ||
Medical condition: BETA BLOCKADE AND LUNG FUNCTION | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004891-16 | Sponsor Protocol Number: CL3-05179-002 | Start Date*: 2021-10-20 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Evaluation of the clinical efficacy and safety of perindopril 10 mg/indapamide 2.5 mg/amlodipine 5 or 10 mg/bisoprolol 5 mg in single-pill combination after 8 weeks of treatment versus the free com... | |||||||||||||
Medical condition: Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) PT (Completed) LT (Completed) IT (Ongoing) LV (Completed) SK (Completed) HU (Completed) CZ (Completed) BG (Completed) HR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002699-42 | Sponsor Protocol Number: DANBLOCK | Start Date*: 2018-09-28 | |||||||||||
Sponsor Name:Bispebjerg Frederiksberg Hospital | |||||||||||||
Full Title: Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) | |||||||||||||
Medical condition: Myocardial infarction. We wish to test whether long-term treatment with betablocker (bisoprolol, carvedilol, metoprolol or nebivolol) leads to better prognosis than no treatment in patients sufferi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000239-34 | Sponsor Protocol Number: PONTIACII | Start Date*: 2015-12-30 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial | ||
Medical condition: The purpose of this study is to evaluate the effect of high dose Renin-Angiotensin System (RAS)-antagonists and beta-blocker treatment for the primary prevention of cardiac events in a population o... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) NL (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000751-13 | Sponsor Protocol Number: MS20006/00042 | Start Date*: 2019-07-02 | |||||||||||
Sponsor Name:Fundacja “Centrum Rozwoju Medycyny” | |||||||||||||
Full Title: Efficacy and safety of Concor 5mg plus amlodipine 5mg in hypertensive patients whose blood pressure cannot be controlled under 5mg of amlodipine monotherapy, a phase III multicentre, randomised, do... | |||||||||||||
Medical condition: hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003260-37 | Sponsor Protocol Number: 1060 | Start Date*: 2015-10-22 | ||||||||||||||||||||||||||
Sponsor Name:Liverpool Heart and Chest Hospital | ||||||||||||||||||||||||||||
Full Title: Can Ivabradine attenuate post-revascularisation microcirculatory dysfunction in flow limiting coronary artery disease? | ||||||||||||||||||||||||||||
Medical condition: Coronary Artery Disease/Angina | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001228-20 | Sponsor Protocol Number: CAMG334A2401 | Start Date*: 2019-04-11 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A 12-month prospective, randomized, interventional, global, multi-center, active-controlled study comparing sustained benefit of two treatment paradigms (erenumab qm vs. oral prophylactics) in adul... | |||||||||||||
Medical condition: Migraine prevention | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) CZ (Completed) FI (Completed) GB (GB - no longer in EU/EEA) SK (Completed) PT (Completed) GR (Completed) PL (Completed) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.